BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 25474039)

  • 1. Cancer associated fibroblasts in hematological malignancies.
    Raffaghello L; Vacca A; Pistoia V; Ribatti D
    Oncotarget; 2015 Feb; 6(5):2589-603. PubMed ID: 25474039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts in digestive tumors.
    Huang L; Xu AM; Liu S; Liu W; Li TJ
    World J Gastroenterol; 2014 Dec; 20(47):17804-18. PubMed ID: 25548479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
    Peng Y; Li Z; Li Z
    Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging targets for hematological malignancies.
    Cilloni D; Frassoni F; Saglio G
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):548-58. PubMed ID: 20812146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid, CYP26, and drug resistance in the stem cell niche.
    Alonso S; Jones RJ; Ghiaur G
    Exp Hematol; 2017 Oct; 54():17-25. PubMed ID: 28754309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.
    Horne GA; Copland M
    Expert Opin Drug Discov; 2017 May; 12(5):465-474. PubMed ID: 28277836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.
    Weber CE; Kothari AN; Wai PY; Li NY; Driver J; Zapf MA; Franzen CA; Gupta GN; Osipo C; Zlobin A; Syn WK; Zhang J; Kuo PC; Mi Z
    Oncogene; 2015 Sep; 34(37):4821-33. PubMed ID: 25531323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin.
    McDonald LT; LaRue AC
    Int J Clin Exp Pathol; 2012; 5(9):863-73. PubMed ID: 23119103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment.
    Kinugasa Y; Matsui T; Takakura N
    Stem Cells; 2014 Jan; 32(1):145-56. PubMed ID: 24395741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bone marrow niche in support of breast cancer dormancy.
    Walker ND; Patel J; Munoz JL; Hu M; Guiro K; Sinha G; Rameshwar P
    Cancer Lett; 2016 Sep; 380(1):263-71. PubMed ID: 26546045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematological malignancies: disease pathophysiology of leukemic stem cells.
    Ramdass B; Chowdhary A; Koka PS
    J Stem Cells; 2013; 8(3-4):151-87. PubMed ID: 24699024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone Marrow Micro-Environment in Normal and Deranged Hematopoiesis: Opportunities for Regenerative Medicine and Therapies.
    Sarkaria SM; Decker M; Ding L
    Bioessays; 2018 Mar; 40(3):. PubMed ID: 29384206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypoxia signalling pathway in haematological malignancies.
    Irigoyen M; García-Ruiz JC; Berra E
    Oncotarget; 2017 May; 8(22):36832-36844. PubMed ID: 28415662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies.
    Yoshida GJ; Azuma A; Miura Y; Orimo A
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067787
    [No Abstract]   [Full Text] [Related]  

  • 16. Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment.
    Seke Etet PF; Vecchio L; Bogne Kamga P; Nchiwan Nukenine E; Krampera M; Nwabo Kamdje AH
    Biochim Biophys Acta; 2013 Jan; 1835(1):1-10. PubMed ID: 22982245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Microenvironment: What Can We Learn from the Stem Cell Niche.
    Lacina L; Plzak J; Kodet O; Szabo P; Chovanec M; Dvorankova B; Smetana K
    Int J Mol Sci; 2015 Oct; 16(10):24094-110. PubMed ID: 26473842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles in hematological malignancies.
    Litwińska Z; Łuczkowska K; Machaliński B
    Leuk Lymphoma; 2019 Jan; 60(1):29-36. PubMed ID: 29745272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1 in hematological malignancies.
    Stroopinsky D; Kufe D; Avigan D
    Leuk Lymphoma; 2016 Nov; 57(11):2489-98. PubMed ID: 27347699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment.
    McDonald LT; Russell DL; Kelly RR; Xiong Y; Motamarry A; Patel RK; Jones JA; Watson PM; Turner DP; Watson DK; Soloff AC; Findlay VJ; LaRue AC
    Neoplasia; 2015 May; 17(5):434-48. PubMed ID: 26025666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.